Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Antiviral”

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00002169
What this trial is testing

Viracept in AIDS Patients With Cytomegalovirus Retinitis

Who this might be right for
Cytomegalovirus RetinitisHIV Infections
Agouron Pharmaceuticals
Not applicableNot Yet RecruitingNCT05705141
What this trial is testing

The Effect of Metabolic Syndrome on Antiviral Response in People With Chronic Hepatitis B

Who this might be right for
Chronic Hepatitis b
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 1,000
Large-scale testing (Phase 3)Study completedNCT00975091
What this trial is testing

Continue Entecavir Rollover From China

Who this might be right for
Chronic Hepatitis B Virus
Bristol-Myers Squibb 600
Large-scale testing (Phase 3)Study completedNCT04231968
What this trial is testing

AK0529 in Chinese Infants Hospitalized With RSV

Who this might be right for
Respiratory Syncytial Virus Infections
Shanghai Ark Biopharmaceutical Co., Ltd. 311
Not applicableStudy completedNCT00000635
What this trial is testing

Treatment of Acyclovir-Resistant Mucocutaneous Herpes Simplex Disease in Patients With AIDS: Open Label Pilot Study of Topical Trifluridine

Who this might be right for
Herpes SimplexHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 25
Early research (Phase 1)UnknownNCT00811408
What this trial is testing

Cidofovir in Treating Patients With Stage IB, Stage II, Stage III, or Stage IVA Cervical Cancer Who Are Receiving Chemotherapy and Radiation Therapy

Who this might be right for
Cervical CancerPrecancerous Condition
Gustave Roussy, Cancer Campus, Grand Paris 24
Large-scale testing (Phase 3)Study completedNCT04021290
What this trial is testing

Regimen Switch to Dolutegravir/Lamivudine Fixed Dose Combination From Current Antiretroviral Regimen in HIV-1 Infected and Virologically Suppressed Adults (SALSA)

Who this might be right for
HIV Infections
ViiV Healthcare 493
Testing effectiveness (Phase 2)Study completedNCT02743897
What this trial is testing

Transplanting Hepatitis C Kidneys Into Negative Kidney Recipients

Who this might be right for
End Stage Renal Disease
University of Pennsylvania 62
Large-scale testing (Phase 3)Study completedNCT02996682
What this trial is testing

Efficacy and Safety of Sofosbuvir/Velpatasvir ± Ribavirin for 12 Weeks in Adults With Chronic HCV Infection and Decompensated Cirrhosis

Who this might be right for
Hepatitis C Virus Infection
Gilead Sciences 102
Testing effectiveness (Phase 2)Study completedNCT04147208
What this trial is testing

Evaluate the Safety, Tolerability, and Antiviral Activity of GLS4 With Ritonavir in Patients With Chronic HBV Infection

Who this might be right for
Chronic HBV Infection
Sunshine Lake Pharma Co., Ltd. 250
Testing effectiveness (Phase 2)Study completedNCT00001068
What this trial is testing

Disease Progression and Anti-HIV Treatments

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 210
Post-approval studies (Phase 4)UnknownNCT01894269
What this trial is testing

Chemoembolization With or Without Antiviral Therapy for Unresectable HBV-related HCC With Low HBV DNA Replication

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 200
Testing effectiveness (Phase 2)Looking for participantsNCT05587894
What this trial is testing

OPtimisation of Antiviral Therapy in Immunocompromised COVID-19 Patients: a Randomized Factorial Controlled Strategy Trial

Who this might be right for
COVID-19Immunodeficiency
ANRS, Emerging Infectious Diseases 256
Not applicableStudy completedNCT03612973
What this trial is testing

Changes in Liver Fibrosis, Lipid Profile and Insulin Resistance in HCV Patients Who Received Antiviral Therapy

Who this might be right for
Chronic Hepatitis c
Assiut University 80
Testing effectiveness (Phase 2)Study completedNCT00680342
What this trial is testing

Phase II Trial of Silymarin for Patients With Chronic Hepatitis C Who Have Failed Conventional Antiviral Treatment

Who this might be right for
Chronic Hepatitis C
National Center for Complementary and Integrative Health (NCCIH) 154
Not applicableUnknownNCT02772744
What this trial is testing

Determining the Sustained Virologic Response of Declatasvir in Egyptian Patients With Hepatitis C Virus Genotype 4

Who this might be right for
Hepatitis C
Zagazig University 250
Not applicableUnknownNCT03775798
What this trial is testing

Incidence of de Novo Hepatocellular Carcinoma After Antiviral Agents for HCV.

Who this might be right for
Hepatitis CCirrhosisAntiviral Drug Adverse Reaction
Austral University, Argentina 2,200
Testing effectiveness (Phase 2)Study completedNCT02356562
What this trial is testing

Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With or Without Sofosbuvir and Ribavirin in Direct-Acting Antiviral Agent Treatment-Experienced Adults With Chronic Hepatitis C Virus Infection

Who this might be right for
Chronic Hepatitis C Infection
AbbVie 29
Early research (Phase 1)Study completedNCT01313962
What this trial is testing

Safety Study of Flufirvitide-3 Nasal Spray in Healthy Subjects

Who this might be right for
Influenza
Autoimmune Technologies, LLC 32
Testing effectiveness (Phase 2)Ended earlyNCT04906980
What this trial is testing

JNJ-64281802 in Participants With Confirmed Dengue Fever

Who this might be right for
Dengue
Janssen Research & Development, LLC 5
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation